β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis

por Li, Chaoran, Li, Tian, Tang, Runwei, Yuan, Shuai, Zhang, Weihong
Publicado 2020

Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway

por Zhou, Qianmei, Zhang, Weihong, Li, Tian, Tang, Runwei, Li, Chaoran, Yuan, Shuai, Fan, Desheng
Publicado 2019